KEY POINTS
  • The U.S. paused use of the J&J Covid-19 vaccine for 10 days to investigate rare cases of blood clots, before recommending its use again April 23.
  • Before the pause, more than a quarter of people who were unvaccinated said they'd choose the J&J vaccine, the only one-dose option.
  • Now, that number has declined, but 17% still say it's their top choice.
Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, March 3, 2021.

Fewer Americans say they prefer the Johnson & Johnson Covid-19 vaccine after the U.S. temporarily paused its use in April, but 17% of Americans in a new survey still say it's their top choice.

That's down from 29% in March, before the pause, according to consecutive surveys of more than 1,500 Americans done for CNBC by global data and survey firm Dynata.